financetom
Business
financetom
/
Business
/
ED seizes ₹5-crore worth cash, jewellery after fresh searches against ABG Shipyard
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ED seizes ₹5-crore worth cash, jewellery after fresh searches against ABG Shipyard
Nov 29, 2023 1:51 PM

The Enforcement Directorate (ED) on Wednesday said it has seized cash and jewellery worth about ₹5 crore after fresh searches against ABG Shipyard and others as part of a money laundering probe linked to an alleged bank loan fraud.

The searches were undertaken on November 24 at seven locations in Mumbai, Pune, and Delhi. The central agency undertook searches in this case first time in April 2022.

"The searches were conducted at the residences of the persons, family members related to ABG Shipyard Ltd and its related group companies which resulted in the recovery and seizure of unaccounted cash, bullion and jewellery to the tune of Rs 5 crore," the ED said in a statement.

The money laundering case stems from the FIR filed by the Central Bureau of Investigation (CBI) against the company for causing a loss to the tune of ₹22,842 crore to a consortium of banks led by ICICI Bank.

Also Read: ED notice related to technical issue on FDI, expects nominal fine: Byju's

ABG Shipyard and its group companies availed various credit/loan facilities from the consortium of banks for the purpose of working capital requirement and capital expenditure and some other purposes, it said.

However, ABG Shipyard and its group companies "utilised huge funds for purposes other than its stated use and diverted the same through various group companies incorporated in India and abroad," the ED alleged. The agency has attached assets worth a total ₹2,747.69 crore in this case till now and has earlier filed a charge sheet.

ABG Shipyard has been a major player in the Indian shipbuilding industry and operated from its shipyards located at Dahej and Surat in Gujarat with the capacity to build vessels up to 18,000 dead weight tonnage at Surat shipyard and 1,20,000 dead weight tonnage at Dahej shipyard.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Analysis-Mexico free trade with US may survive as Trump spares it from new tariffs, hits rivals
Analysis-Mexico free trade with US may survive as Trump spares it from new tariffs, hits rivals
Apr 3, 2025
MEXICO CITY (Reuters) - President Donald Trump's Liberation Day appeared set to end North American free trade and Mexico's privileged access to the U.S.  Instead, Mexican officials are celebrating being left off Trump's global tariffs list, with analysts suggesting the omission could prolong North American free trade.  On a day in which nearly all countries were hit with at least...
Sector Update: Consumer
Sector Update: Consumer
Apr 3, 2025
03:35 PM EDT, 04/03/2025 (MT Newswires) -- Consumer stocks were mixed late Thursday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) rising 0.6% and the Consumer Discretionary Select Sector SPDR Fund (XLY) dropping 6.1%. In sector news, President Donald Trump's auto tariffs will likely cost US car buyers about $30 billion in the first year, assuming carmakers will...
Stellantis to idle Michigan plant for several weeks due to engine shortage
Stellantis to idle Michigan plant for several weeks due to engine shortage
Apr 3, 2025
April 3 (Reuters) - Chrysler-parent Stellantis ( STLA ) said on Thursday it is idling a plant in Warren, Michigan, for several weeks due to a shortage of engines. It said the issue is unrelated to new U.S. auto tariffs. The automaker said it is allocating all available engines to support production of the Ram 1500 at the Sterling Heights...
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
Apr 3, 2025
(Reuters) -The U.S. Food and Drug Administration has approved expanded use of Amgen's ( AMGN ) drug, Uplizna, to help reduce the risk of flares in patients with a rare immune system-related condition, the regulator said on Thursday. The drug, also known as inebilizumab, has now become the first FDA-approved treatment for Immunoglobulin G4-related disease (IgG4-RD), a rare condition in...
Copyright 2023-2025 - www.financetom.com All Rights Reserved